"Multi-Omics Research of Danhong Injection to Treat Acute Ischemic Stroke"

PHASE4CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

March 31, 2019

Study Completion Date

July 31, 2020

Conditions
Acute Stroke
Interventions
DRUG

Danhong injection

40ml Danhong injection added into 250ml 0.9% saline by an independent research nurse, sealed with brown bag in order to make the investigators and patients blinded, using brown infusion tube for infusion

PROCEDURE

Standard medical care

Standard medical care is in accordance with China Guideline for the diagnosis and treatment of acute ischemic stroke (2010), including medical care for vital signs, control of temperature, blood pressure and glucose, improving cerebral blood circulation, antiplatelet treatment and nutritional supportive care.

DRUG

placebo

0.9% saline added into 250ml 0.9% saline by an independent research nurse, sealed with brown bag in order to make the investigators and patients blinded, using brown infusion tube for infusion

Trial Locations (4)

124013

Panjin Central Hospital, Panjin

473065

Nanshi Hospital of Nanyang, Nanyang

Unknown

202 Military Hospital of China, Shenyang

024005

Affiliated Hospital of Chifeng University, Chifeng

All Listed Sponsors
collaborator

China Food and Drug Administration

OTHER_GOV

lead

China Academy of Chinese Medical Sciences

OTHER

NCT02176395 - "Multi-Omics Research of Danhong Injection to Treat Acute Ischemic Stroke" | Biotech Hunter | Biotech Hunter